About us
Cancilico: Pioneering AI in Image-Based Diagnostics
At Cancilico, we are dedicated to transforming the way diseases such as hematological cancers are diagnosed and studied. Our mission is to harness the power of AI to revolutionize medical diagnostics, making it more accurate, efficient, and accessible.
Our people
Team
-
Markus Badstübner
CEO
-
Sebastian Riechert
CAIO
-
Tim Schmittmann
CTO
-
Kasper Malfroid
CPO
-
Katja Siegert
Head, Q&RA
-
Oleksii Kulinich
Senior Full Stack Developer
-
Chethan Babu
Head of AI R&D, Pharma
-
Masoumeh Javanbakht
Senior AI Engineer
-
Dr.-Ing. Karsten Wendt
Soft-Tech Consultant
-
Dr. med. Jan Moritz Middeke
CMO
-
Dr. med. Jan-Niklas Eckardt
CSO
-
Jacek Lesinski
Hematology Specialist
Governance
Board
-
Prof. em. Dr. med. Gerhard Ehninger
A serial entrepreneur, renowned clinician, researcher and former Head of Hematology & Oncology at University Hospital Carl Gustav Carus Dresden
-
Jörg Traub
Principal at High-Tech Gründerfonds (HTGF) and former medtech founder, with deep expertise in medical imaging, digital health and scaling university spin-offs from idea to exit
-
David Rittrich
Architect for data-driven businesses with a strong background in cloud transformation and focus on data engineering
-
Roland Oetker
Founder and managing partner of investment firm ROI, a long-standing biotech and medtech investor
-
Oliver Latz
Principal investment manager and head of life-science investments at Technologiegründerfonds Sachsen (TGFS), backing innovative Saxon technology and healthcare startups
Expertise
Scientific Advisors
-
Sanam Loghavi, M.D.
Associate Professor of Hematopathology at the University of Texas MD Anderson Cancer Center
-
Dr. med. Anne Marie Asemissen
Leading senior physician at Malteser Krankenhaus St. Franziskus-Hospital, Flensburg
-
Sabine Haase
Lead Medical Technologist for Laboratory Analytics at the Specialized Hematology Laboratory, Marien Hospital Düsseldorf
-
Dr. med. Stefani Parmentier
Distinguished Hematologist and leading Physician at the Claraspital Basel Tumor Center
-
Prof. Dr. med. Martin Bornhäuser
Director of Medical Clinic I at University Hospital Carl Gustav Carus and at the National Center for Tumor Diseases Dresden, and Professor for Hematology/Oncology
-
Prof. Stephen Gilbert
Professor at Dresden University of Technology (Else Kröner Fresenius Center for Digital Health - EKFZ) with more than 15 years of experience in regulatory science and expertise in medical and IVD regulations
-
Dr. med. Katja Sockel
Senior Physician for Hematology/Oncology at Carl Gustav Carus University Hospital Dresden and Deputy Head of the Laboratory for Hematologic Cytology with clinical & research focus in myeloid neoplasia